Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Persistence targeted smoking cessation for smokers with schizophrenia or schizoaffective disorder: a feasibility study

AI Summary
  • Smokers with schizophrenia smoke more and quit less; reduced task persistence may contribute to quitting difficulties.
  • Intervention feasible and acceptable: 93.8% found it easy to understand; 81.3% found it helpful; 62.5% attended at least six sessions.
  • Future research should evaluate initial efficacy and examine task persistence as a mediator of smoking cessation outcomes.
Summarise with AI (MRCPsych/FRANZCP)

J Smok Cessat. 2020 Sep;15(3):157-162. doi: 10.1017/jsc.2020.19. Epub 2020 Jul 9.

ABSTRACT

INTRODUCTION: Individuals with schizophrenia are more likely to smoke and less likely to quit smoking than those without schizophrenia. Because task persistence is lower in smokers with than without schizophrenia, it is possible that lower levels of task persistence may contribute to greater difficulties in quitting smoking observed among smokers with schizophrenia.

AIMS: To develop a feasible and acceptable intervention for smokers with schizophrenia.

METHODS: Participants (N = 24) attended eight weekly individual cognitive behavioral therapy sessions for tobacco use disorder with a focus on increasing task persistence and received 10 weeks of nicotine patch.

RESULTS: In total, 93.8% of participants rated the intervention as at least a 6 out of 7 regarding how ‘easy to understand’ it was and 81.3% rated the treatment as at least a 6 out of 7 regarding how helpful it was to them. A total of 62.5% attended at least six of the eight sessions and session attendance was positively related to nicotine dependence and age and negatively related to self-efficacy for quitting.

DISCUSSION: This intervention was feasible and acceptable to smokers with schizophrenia. Future research will examine questions appropriate for later stages of therapy development such as initial efficacy of the intervention and task persistence as a mediator of treatment outcome.

PMID:42597987 | PMC:PMC13470118 | DOI:10.1017/jsc.2020.19

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD